In the PIVOT-02 study (NCT02983045) study, the improved objective response rate and progression-free survival were observed in baseline tumor biopsies with high IFN-γ GEP, high CD8+ TIL, high CD74, and high HLA-E. This evidence concerns the gene CD8A and neoplasm.